Genetic Polymorphisms in Metabolizing Enzymes Modifying the Association Between Smoking and Inflammatory Bowel Diseases

Background:Cigarette smoking is a well-established environmental risk factor for Crohn's disease (CD) and ulcerative colitis (UC). The exact mechanism of its effect remains unexplained. Genetic polymorphisms in metabolizing enzymes may influence susceptibility to the effect of smoking and shed light on its mechanism of action. Methods:We used a prospective cohort of patients with CD, UC, and healthy controls. Smoking status was defined as current, former, or never smoking. Patients were genotyped for polymorphisms in CYP2A6, glutathione transferase enzymes (GSTP1 and GSTM1), NAD(P)H quinone oxidoreductase (NQO), and heme oxygenase 1 using a Sequenom platform. Multivariate logistic regression models with CD or UC as the outcome, stratified by genotype, were developed and interaction P-values calculated. Results:Our study included 634 patients with CD, 401 with UC, and 337 healthy controls. Ever smokers had an increased risk of CD (odds ratio = 3.88, 95% confidence interval = 2.35–6.39) compared with nonsmokers among patients with AG/AA genotypes at CYP2A6. However, ever smoking was not associated with CD among patients with the AA genotype (Pinteraction = 0.001). Former smoking was associated with an increased risk for UC only in the presence of GG/AG genotypes for GSTP1 but not in those with the AA genotype (Pinteraction = 0.012). Polymorphisms at the NQO and HMOX loci did not demonstrate a statistically significant interaction with smoking and risk of CD or UC. Conclusions:Genetic polymorphisms in metabolizing enzymes may influence the association between smoking and CD and UC. Further studies of gene–environment interaction in inflammatory bowel disease are warranted.

[1]  Ta-Chiang Liu,et al.  Genetics and Pathogenesis of Inflammatory Bowel Disease. , 2016, Annual review of pathology.

[2]  Wei-Qing Chen,et al.  Influence of CYP2A6*4 genotypes on maternal serum cotinine among Chinese nonsmoking pregnant women. , 2014, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[3]  L. Bierut,et al.  Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms. , 2014, Human molecular genetics.

[4]  U. Vogel,et al.  Interactions between Diet, Lifestyle and IL10, IL1B, and PTGS2/COX-2 Gene Polymorphisms in Relation to Risk of Colorectal Cancer in a Prospective Danish Case-Cohort Study , 2013, PloS one.

[5]  R. Tyndale,et al.  CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers , 2013, Pharmacogenetics and genomics.

[6]  R. Leong,et al.  Review article: ulcerative colitis, smoking and nicotine therapy , 2012, Alimentary pharmacology & therapeutics.

[7]  A. Chan,et al.  A Prospective Study of Cigarette Smoking and the Risk of Inflammatory Bowel Disease in Women , 2012, The American Journal of Gastroenterology.

[8]  H. Sokol,et al.  Current smoking differentially affects blood mononuclear cells from patients with crohn's disease and ulcerative colitis: Relevance to its adverse role in the disease , 2012, Inflammatory bowel diseases.

[9]  L. Le Marchand,et al.  Heterocyclic amine intake, smoking, cytochrome P450 1A2 and N-acetylation phenotypes, and risk of colorectal adenoma in a multiethnic population , 2012, Gut.

[10]  S. David,et al.  Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways. , 2011, European journal of endocrinology.

[11]  M. Spitz,et al.  Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. , 2011, Journal of the National Cancer Institute.

[12]  D. Rachmilewitz,et al.  Relationship between CYP2A6 genetic polymorphism, as a marker of nicotine metabolism, and ulcerative colitis. , 2011, The Israel Medical Association journal : IMAJ.

[13]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[14]  M. Hiratsuka,et al.  Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan. , 2011, Drug metabolism and pharmacokinetics.

[15]  S. Nikfar,et al.  Systematic review and meta-analysis of the efficacy and tolerability of nicotine preparations in active ulcerative colitis. , 2010, Clinical therapeutics.

[16]  E. Karlson,et al.  Effect of interactions of glutathione S-transferase T1, M1, and P1 and HMOX1 gene promoter polymorphisms with heavy smoking on the risk of rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[17]  J. Grunewald,et al.  Smoking, use of moist snuff, and risk of chronic inflammatory diseases. , 2010, American journal of respiratory and critical care medicine.

[18]  Ming D. Li,et al.  Genome-wide meta-analyses identify multiple loci associated with smoking behavior , 2010, Nature Genetics.

[19]  J. Seagrave,et al.  Effects of 10 cigarette smoke condensates on primary human airway epithelial cells by comparative gene and cytokine expression studies. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  H. Sokol,et al.  Effects of light smoking consumption on the clinical course of Crohn's disease , 2009, Inflammatory bowel diseases.

[21]  Vibeke Andersen,et al.  Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study , 2009, BMC Cancer.

[22]  J. Cosnes.  What is the link between the use of tobacco and IBD? , 2008, Inflammatory bowel diseases.

[23]  M. Parsi.  Does smoking decrease the response to infliximab in patients with Crohn's disease? , 2008, Inflammatory bowel diseases.

[24]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[25]  S. Galandiuk,et al.  Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.

[26]  C. Jepson,et al.  Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy , 2006, Molecular Psychiatry.

[27]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[28]  U. Böcker,et al.  Inflammatory Bowel Disease and Smoking: A Review of Epidemiology, Pathophysiology, and Therapeutic Implications , 2004, Inflammatory bowel diseases.

[29]  J. Cosnes.  Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. , 2004, Best practice & research. Clinical gastroenterology.

[30]  L. Beaugerie,et al.  Gender differences in the response of colitis to smoking. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[31]  F. Carbonnel,et al.  Smoking cessation and the course of Crohn's disease: an intervention study. , 2001, Gastroenterology.

[32]  A. Zinsmeister,et al.  Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival , 2000, Gut.

[33]  F. Carrat,et al.  Effects of current and former cigarette smoking on the clinical course of Crohn’s disease , 1999, Alimentary pharmacology & therapeutics.

[34]  A. Zinsmeister,et al.  Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. , 1998, Gastroenterology.

[35]  R Ottman,et al.  Gene-environment interaction: definitions and study designs. , 1996, Preventive medicine.

[36]  F. Carbonnel,et al.  Effects of cigarette smoking on the long-term course of Crohn's disease. , 1996, Gastroenterology.

[37]  H. Sørensen,et al.  Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system. , 1996, Scandinavian journal of gastroenterology.

[38]  J. Hayes,et al.  Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. , 1995, Free radical research.

[39]  S. Srivastava,et al.  Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. , 1994, European journal of biochemistry.

[40]  A. Ahlbom,et al.  Use of oral moist snuff and inflammatory bowel disease. , 1993, International journal of epidemiology.

[41]  V. Daniel,et al.  Glutathione S-transferases: gene structure and regulation of expression. , 1993, Critical reviews in biochemistry and molecular biology.

[42]  A. Harries,et al.  Non-smoking: a feature of ulcerative colitis. , 1982, British medical journal.